ABSTRACT
The predicted secretome of the opportunistic fungal pathogen Candida albicans contains more than 200 ORFs of diverse and often unknown function. Majority of the secreted proteins that have been experimentally evaluated to date are hydrolytic enzymes (proteinases, phospholipases and lipases). Acting on the interface between the pathogen and the host, the secreted hydrolases may enable invasion of host tissues, help the pathogen to avoid host defense mechanisms, or allow the microorganism to utilize host cell macromolecules as a source of nutrients. Aspartic proteinases constitute the bestcharacterized family of the C. albicans secreted proteins. Number of studies addressed also secreted phospholipases. Lipases and N-acetylhexosaminidase have received less attention thus far. Many ORFs that are predicted to encode secreted proteins await characterization.
INTRODUCTION
The genus Candida comprises about 150 yeast species, and approximately 17 of them are associated with opportunistic infections of humans and other mammals (1) . Of these, C. albicans is the most frequently encountered species in clinical practice. It causes a wide spectrum of diseases, ranging from superficial mycoses to disseminated infections with high mortality rates. Pathogenic Candida spp. can live in human or animal hosts as harmless commensals, being kept under the control by the host immune system. However, in a susceptible host, a transition of Candida from commensal to pathogen can occur. This transition is governed by host-pathogen interactions and is likely to require not only impairment of the host immune system but also an active contribution of the fungus (2). The reasons to study the pathogenic Candida spp. are related in the first place to the needs of medical treatment and protection of the individuals with weak or impaired immune systems. Population of the immunocompromised individuals has expanded and the frequency of infections due to the Candida spp. has increased over the past two decades. This fact has prompted the research that resulted in a progress of the development of antifungal drugs and diagnostic tools (3). Although various antimycotics have been marketed, the number of therapeutical strategies for critically ill patients is limited. While the superficial mycoses can be relatively mild and easy to cure, we still have problems to prevent and treat the systemic infections.
The efforts aimed at the design of novel antifungals and diagnostic approaches produced a remarkable pool of scientific data. Thus, pathogenic Candida spp., and particularly C. albicans has become an attractive and powerful model to study a range of biological phenomena. C. albicans was one of the first eukaryotic pathogens whose genome was sequenced. The completed diploid genome sequence was published in 2004 (4) and the annotations in 2005 (5, 6). The unfinished sequences were made available to the community earlier to advance the understanding of the C. albicans pathogenicity. The latest and the most complete C. albicans genome sequence (Assembly 21) was released in September 2007. The haploid genome consists of 15.845 Mb of DNA organized into the 8 chromosomes, and contains 6109 predicted protein-coding genes (7) . The main repository of genomic sequence data, and information on genes/proteins that have been studied so far is the Candida Genome Database (CGD, www.candidagenome.org).
According to the CGD annotation, 41 genes have been identified to date that encode proteins secreted to the extracellular space. However, the secretion has not been experimentaly demonstrated for all of these proteins. In some cases, the extracellular localization is inferred from electronic annotation. The list of predicted extracellular proteins was further extended by application of bioinformatics methods. Lee et al. identified 283 C. albicans ORFs with N-terminal signal peptide but without transmembrane domains, GPI-anchor and mitochondrial or other localization signal (8) . These ORFs encode proteins of diverse and often unknown functions. Only 38 ORFs of this set were found to encode known C. albicans proteins or members of known families. In fact, gene/protein families form a large part of the list of known ORFs in the predicted C. albicans secretome.
The set of secreted proteins in principle comprises not only the proteins that can be recovered from the cell-free culture supernatants, but also those proteins that are displayed extracellularly, but remain linked to the cell surface. This review is, however, focused mostly on the entirely secreted proteins. Although they may be temporarily retained in the cell wall, they do not form covalent bonds to the cell surface structures.
All of the proteins falling into this category are hydrolytic enzymes (Table 1) . Pathogenic microbes often possess a repertoire of secreted hydrolases, namely proteinases, lipases and phospholipases, which facilitate the pathogen invasion of the host cells. These enzymes may also allow microorganisms to utilize host cell macromolecules as a source of nutrients. The secretion of extracellular proteinases, lipases and phospholipases by C. albicans was first reported in 1960s (9, 10) . The enzyme secretion was observed when the yeasts were cultivated on solid media containing either bovine serum albumin (proteinases) or egg yolk (lipases, phospholipases). Breakdown of the protein or lipid/phospholipid substrates resulted in a halo or precipitation zone, proportional to the activity of the hydrolases secreted by the yeast colonies. The optimized and simplified plate assays are still being used for rapid, gross screening of hydrolase activities, particularly in the studies monitoring a large number of clinical isolates (11) (12) (13) (14) (15) (16) .
The observation of extracellular proteolytic and lipolytic activities initiated extensive studies of secreted hydrolases, especially proteinases of C. albicans and other pathogenic Candida spp. The gene families encoding these enzymes were described, and the individual genes were found to be expressed differentially, depending on environmental factors and life stage of the fungus. While the phospholipase B activity has been detected also in Saccharomyces cerevisiae culture supernatants (17) , secreted proteinases and lipases do not have any S. cerevisiae counterparts. Some of the hydrolase isoenzymes were studied on enzymological level and crystal structures of several secreted proteinases were solved. The reader is directed to excellent reviews discussing the topics of secreted proteinases (18) (19) (20) (21) , phospholipases (22) (23) (24) , or hydrolazes in general (25) . The aim of this review is to put forward the recent advancement of the research focused on secreted hydrolases of C. albicans, and to bring together the information on known representatives of the secretome of this fungus.
PROTEINASES
Proteinases, proteases or peptidases are ubiquitous enzymes that catalyze hydrolysis of peptide bonds. They are responsible for protein processing or degradation. Proteinases are classified according to the catalytic type, i.e. according to the characteristic amino acid residues in the active site. Aspartic, cystein, glutamic, serine, threonine and metallopeptidases have been described to date (26). Aspartic proteinases have been found in viruses, plants, vertebrates and fungi, but not in bacteria. They are active at acidic pH and are specifically inhibited by pepstatin. Two aspartic acid residues that are responsible for the catalytic activity occur within the conserved sequence motifs Asp-Thr/Ser-Gly. Aspartic proteinases play important roles in a range of diseases including hypertension, cancer, Alzheimer's disease, or viral and microbial infections (27). Extracellular aspartic proteinases are produced by Aspergillus fumigatus (28, 29) and several pathogenic Candida species. The family of secreted aspartic proteinases (SAP) is undoubtedly the bestcharacterized set of proteins secreted by C. albicans.
While the C. albicans SAP family consists of ten members, four genes encoding secreted aspartic proteinases have been identified in C. tropicalis (30) and three in C. parapsilosis (31, 32) . As the C. parapsilosis and C. tropicalis genomes are currently being annotated, the number of the aspartic proteinases secreted by these species will soon become more accurate. C. glabrata does not produce significant levels of extracellular proteolytic activity. Nevertheless, it possesses a family of orthologs of the S. cerevisiae extracellular GPIlinked aspartic proteases that play a role in virulence (33). The extracellular GPI-anchored aspartic proteinases have been identified also in C. albicans. They are denominated Sap9 and Sap10, and are likely to play a role in the cell wall integrity and in the C. albicans adhesion to the host cells (34). The isoenyzmes Sap1-6 and Sap8 are secreted to the extracellular space and can be recovered from the culture supernatants (35-37). The extracellular localization of Sap7 was predicted (8) .
The Sap-producing Candida spp. secret one major aspartic proteinase in vitro, in culture media containing exogenous protein as a sole source of nitrogen. In C. albicans, this isoenyzme is denominated Sap2. The C. tropicalis and C. parapsilosis orthologs are termed Sapt1p and Sapp1p, respectively. These proteinases are relatively easy to obtain in laboratory conditions and therefore they have been characterized in more detail than the other Sap isoenzymes.
Properties and inhibition of the secreted aspartic proteinases
The crystal structures of three aspartic proteinases secreted by two pathogenic Candida spp. have been published: Sap2 and Sap3 from C. albicans and Sapt1p from C. tropicalis (38-41). These structures reveal a typical pepsin-like two-domain architecture, formed mainly by beta-strands ( Figure 1A ). At the junction of the two domains is an extended substrate-binding cleft, which contains the two catalytic aspartate residues, each contributed by one domain.
While the GPI-anchored proteinases Sap9 and Sap10 are highly glycosylated, no glycosylation has been reported for Sap1-Sap8 isoenyzmes. Sap1-Sap3 have optimum activity at pH 3-5 and Sap4-Sap6 at pH 5-7 (21).
Substrate specificity studies have been performed with Sap1, Sap2, Sap3 and Sap6. Although they preferentially hydrolyze bonds formed by hydrophobic residues, the charged amino acids can be accommodated in P1 and P1' positions as well (42,43, Figure 1B ). In general, the specificity of these enzymes is rather broad, reflecting their role in degradation of the host cell substrates, such as fibronectin, laminin (44) casein, denatured collagen (45) or Fc portion of IgG (46). Recently, degradation of E-cadherin in oral epithelial cell junctions has been described and attributed to Sap5 (47).
Pepstatin inhibits most of the secreted aspartic proteinases in nanomolar concentrations. Several studies demonstrated a protective effect of pepstatin in early stages of the C. albicans attack. However, the results obtained in systemic infection models were contradictory (48, 49, other studies are reviewed in 20). Panels of the active site peptidomimetic inhibitors were synthesized and tested in attempts to find a lead structure for the design of novel antimycotics. Although no unambiguously convincing compound has been found, the Sap inhibition and structural The fact that the proteinases secreted by pathogenic Candida spp. and HIV proteinase belong to the same family of aspartic proteinases lead to an idea that HIV proteinase inhibitors may act also against Candida infection. The clinical inhibitors ritonavir, saquinavir, indinavir and nelfinavir interact mostly with S2-S2´ subsites of HIV-1 proteinase (53). In contrast, the binding cleft of the Candida aspartic proteinases is relatively spacious, forming the interactions with pepstatin in S4-S2' subsites (38-40). Thus, the inhibitors of HIV proteinase do not have sufficient contacts with the substrate-binding cleft of the Candida Sap enzymes. The inhibition constants measured for the HIV proteinase inhibitors and the Candida secreted protinases are within micromolar range or poorer (50, 54). Moreover, the inhibitors of HIV proteinase display differential activities against the individual Sap isoenzymes, inhibiting rather Sap1-Sap3 than the other proteinases (55). Saquinavir, indinavir and ritonavir had anticandidal effect in models of oral and vaginal candidiasis, when micromolar concentrations of the inhibitors were used (56-58). On the other hand, only ritonavir was able to block the C. albicans adherence to human endothelial cells, while the other HIV proteinase inhibitors did not have any effect in this experimental setting (59) . These data further support the concept of possible application of the proteinase inhibitors only in the initial stages of the infection. The present-day compounds directed at Sap isoenzymes appear unsuitable for treatment or alleviation of the systemic disease. It is questionable whether the SAP family should be considered as a potential drug target, since most of the successful current antifungals act against functions that are essential rather for growth, than for virulence (3).
Regulation of the proteinases secreted by C. albicans
C. albicans inhabits diverse host niches and many genes are therefore expressed differentially in response to a specific environment. A number of studies have been performed in order to dissect the regulation of the SAP gene family, and the reader is directed to the excellent reviews that summarize results of this research (20, 21, 25) . Expression of the SAP genes depends on many factors including ambient pH, temperature, and nutrient sources which vary according to the type and stage of the disease. The SAP gene control is related also to the morphological transition from yeast to hyphae, and to the cell-type switch between the commonly observed white phase of C. albicans and the opaque, mating-competent phase. The SAP genes are located on five different chromosomes and their promoter regions are distinctive. This allows differential regulation of their transcription, in which several transcription factors are involved. Moreover, the differential regulation may occur even on an allelic level (60) .
SAP1 and SAP3 are regulated by phenotypic switching and were found to be opaque-phase-specific (61, 62) . SAP2 is expressed in both white and opaque phenotypes. Its expression is induced by presence of an exogenous protein and controlled via a positive feedback mechanism (60, 63) . Presence of peptides longer than 7 amino acids can elicit the SAP2 expression as well (64) . SAP2 is activated by transcription factor Stp1, which also activates expression of the genes encoding oligopeptide transporters OPT1 and OPT3. Thus, the degradation of exogenous proteins is co-regulated with the oligopeptide uptake (65) . SAP4-SAP6 are almost exclusively expressed during the hyphal formation at near neutral pH values. These genes are regulated by the factors that also regulate the yeast-hypha transition, particularly by the activator of hypha formation Efg1 (66) . Conversely, the repressor of hyphal development Nrg1 exerts negative effect on the transcription of SAP5 (67) . Hyphal cells are likely to require the expression of the hypha-associated SAP genes during invasion (66) . Expression of SAP5 and SAP6 was increased also during the formation of biofilm (68) . The SAP7 gene and the respective protein are rather enigmatic. The SAP7-specific RNA has not been detected under all the laboratory growth conditions tested and no studies of Sap7 on the protein level have been published. Nevertheless, the SAP7 expression appears to be controlled by the transcription factor Ssn6, as the SAP7 upregulation was observed in the ssn6 null mutant (69) . SAP7 is repressed also by the repressor of yeast-hypha morphogenesis Tup1 (67) . SAP8 is temperature-regulated in vitro, it is expressed at higher levels at 25 °C than at 37 °C and the SAP8-specific mRNA is more abundant in opaque cells (70) .
Although the expression of the secreted proteinases appears to be controlled mainly on the level of transcription, the posttranslational modifications may also play a role in the regulation of the C. albicans extracellular proteolysis. All the SAP genes encode proteinase precursors that contain 60-200 amino acids long pre-prosequence flanking the mature proteinase at the N-terminus. The presequence, i.e. the signal peptide consists of approximately 20 amino acids and is cleaved by a signal peptidase. The propeptide is considered to be removed by the subtilisinlike Kex2 proteinase in the Golgi. The mature aspartic proteinase is then transported to the cell surface and secreted. This concept is supported by the study of Newport and Agabian (71) , who showed that in the kex1 null mutant Sap2 was processed upstream the correct promature junction and its secretion was reduced. On the other hand, Sap1-3 and Sap6 were found to be capable of autocatalytic activation, which indicates that alternative processing pathways exist. Interestingly, in C. parapsilosis one of the Sapp isoenzymes requires activation by a Kex-like proteinase in vitro, while the other can be activated both autocatalytically and in trans (72, 73) . This suggests that distinct processing pathways may be used by the individual proteinases, and that the mode of activation may be a part of the Sap regulatory mechanism.
Role of the secreted aspartic proteinases in virulence of C. albicans
The role of the SAP family in the C. albicans virulence has been reviewed in (20, 21, 54) . The Sap isoenzymes were reported to be involved in adherence, colonization, nutrition and dissemination of C. albicans. Moreover, the secreted proteinases contribute to the induction of the host inflamatory response by the activation of interleukin-beta (74) and stimulating expression of other cytokines (75).
Sap1-Sap3 were found to participate mostly in adhesion of C. albicans to the host cells. The role of these proteinases in the initial stages of the fungal attack and their contribution to mucosal infections has been studied in various models including oral, vaginal or cutaneous infections or reconstituted epithelia (49, 76-78).
SAP4-6 gene products are required for systemic infections. Although temporally distinct patterns of the SAP genes were expresssed during the intraperitoneal infection, SAP4-6 were found to be critical for invasion of parenchymal organs (66) . The Sap4-Sap6 isoenzymes are likely to contribute to virulence by helping Candida to resist the phagocytic attack.
The SAP7 expression was elevated during vaginal infection of mice (79) and in humans with oral candidiasis (80) . The sap7 null mutant exhibited reduced virulence in intravenously infected mice, but surprisingly not in the vaginal infection model (79) . The mechanism by which Sap8 contributes to virulence is also unclear. SAP8 expression in reconstituted human epithelium was found to be regulated temporally. The highest levels of SAP8 transcript occurred only after SAP1, SAP3, SAP6 and SAP2 were already expressed (81).
The role of the SAP family in the C. albicans pathogenesis is still under investigation. The recent additions to the pathogenesis studies include the observations that Sap6 is specifically associated with the C. albicans keratitis (82) and that Sap2 may contribute to aggravation of duodenal ulcers (83) . Nevertheless, the individual Sap isoenzymes appear not to be sufficient to cause the C. albicans invasion. Instead, synergistic effect of more isoenzymes is needed. Mutants lacking an individual SAP gene rarely exhibit a fully avirulent phenotype, because the activities and functions of the Sap isoenzymes overlap (84, 85) .
PHOSPHOLIPASES
Phospholipases catalyze hydrolysis of one or more ester bonds in glycerophospholipids. They perform a variety of important tasks including membrane maintenance or destabilization, and release of lipid second messengers. Phospholipases are classified into four major groups A-D (Figure 2 ). Phospholipases A1 and A2 (PLA) hydrolyze fatty acyl ester bond at sn-1 or sn-2 position, respectively. Group B phospholipases (PLB) display both phospholipase A1 and A2 activities, catalyzing the concomitant removal of both acyl chains from phospholipids. However, phospholipases B of many fungal species are multifunctional enzymes that possess also lysophospholipase activity (Lyso-PL; acylhydrolase activity on monoacylphospholipids), and lysophospholipase-transacylase activity (LPTA; addition of fatty acids to monoacylphospholipids to form corresponding diacylphospholipids). Phospholipases C and D (PLC, PLD) are phosphodiesterases. Phospholipases C hydrolyze glycerophosphate bond, while phospholipases D remove the base group of phospholipids.
Phospholipases of diverse origin are being used in the food industry such as cheese production or baking (86) . On the other hand, they participate in a number of unfavourable phenomena. Phospholipase activity was identified in the snake venom and bacterial toxins (for review see 87, 88) 
Phospholipase B, which possesses also the lyso-PL and LPTA activities, contributes to virulence of Cryptococcus neoformans in animal models (94) . Multifunctional phospholipase B isoenzymes are produced also by Aspergillus fumigatus and considered as potential virulence determinants (95) .
Candida albicans encodes a wide repertoire of phospholipases. All four types of activities, A, B, C and D have been reported. However, the articles published to date differ in the exact number of specific types of phospholipases and their role in virulence. This may be caused by a variety of experimental approaches used, by overlaps among the functions of the individual enzymes, and also by difficulties to distinguish among phospholipases A, B and lysophospholipases. (25, 96) . It seems that the genome of C. albicans does not contain clear sequence homologs of mammalian or bacterial phospholipase A1 and A2 genes. In the reports available up to now, the phospholipase A2 activity has been associated with the PLB5 gene. However, the whole range of biochemical activities that the PLB5 gene product may possess still has to be elucidated (96) .
Five genes denominated PLB are listed in the Candida Genome Database ( Table 1 ). All of them contain N-terminal signal sequence for secretion. Plb3p, Plb4p, and Plb5p additionally contain hydrophobic COOH termini with putative GPI anchor attachment sites. The genes PLB1 and PLB2 encoding proteins without a GPI anchor were cloned (97, 109, 116) , however, only PLB1 has received significant attention. To date, PLB1 is the bestcharacterized member of the C. albicans PLB family, and its gene product is secreted to the extracellular space. Accordingly, PLB1 will be emphasized also in this review.
At least three PLC genes have been identified in C. albicans. None of them contains a signal peptide, and therefore their gene products are not likely to be secreted. Phospholipases C are predicted to be localized in cytoplasm and nucleus. While the first PLC gene identified in C. albicans (named CaPLC1) is an orthologue of PLC1 of S. cerevisiae, the other two genes contain structural elements found in bacterial phospholipases C and do not have any The PLD1 gene encodes the major phosphatidylcholine-specific phospholipase D in C. albicans. The corresponding activity has been localized in the membrane fraction (99) . PLD1 is upregulated during the yeast to hypha transition. When cultivated in liquid media, the pld1 mutant did not show any growth or morphological defects. However, a defect in hyphal growth was observed when the pld1 mutant was subjected to an agar invasion test (100). PLD1 was found to be essential for the C. albicans virulence in the mouse model (101).
Properties of the extracellular phospholipase
Although many phospholipases from various sources have been structurally characterized, no structure of Candida phospholipase has been published to date. Phospholipases B from C. albicans display a significant homology to Plbs from S. cerevisiae, P. notatum or S. pombe (22) . The C. albicans PLB1 gene encodes a protein 605 amino acids long, containing N-glycosylation and possible tyrosine phosphorylation sites. The acylhydrolase activity is usually assayed at pH 4-5. On the other hand, Mirbod et al. reported isolation of a C. albicans secreted enzyme with acylhydrolase and LPTA acitivities exhibiting pH optima at pH 6 (102). Optimum activity for the S. cerevisiae secreted Plb enzymes was observed at pH 2.5 -3.5 (17) .
Substrates of phospholipases are either phospholipids or lysophospholipids consisting of a polar head group (ethanolamine, choline or inositol esterified to phosphoric acid) and one or two non-polar fatty acyl chains esterified to a glycerol backbone. The substrate specificity of phospholipases is determined both by phospho-head groups and by the chain length and saturation of the fatty acyl side chains. Plb1 is strongly inhibited by compounds in which two cationic headgroups are linked by an alkyl spacer. Bisammonium, bispyridinium or bisquinolinium compounds appear to inhibit only Plb1 activity, but not Lyso-PL or LPTA activities. It is not known, which of the three activities is most important for virulence. Nevertheless, some of these compounds have an antifungal effect against C. albicans and Cryptococcus neoformans (103) .
The extracellular LPTA but not Lyso-PL activity was inhibited by palmitoyl carnitine. Presence of palmitoyl carnitine at 300 µM concentration blocked the adhesion of Candida to immobilized lysophospholipids and HEp-2 cells (104) . The LPTA activity of the Cryptococcus Plb1was inhibited by the alkyl phosphocholine drug Miltefosine. When assayed in microdilution test, this compound exhibited antifungal activity against a range of species, including C. albicans (105) .
Antitumor drugs doxorubicin and daunorubicin were reported to block the extracellular Plb activity at concentrations higher than 17 µM. However, the experiments were performed with the whole cell culture and not with purified enzymes. Therefore, the mode of action of these compounds has not been fully clarified (106).
Regulation of the phospholipase secreted by C. albicans
Expression of PLB1 is affected by multiple environmental and physiological stimuli, including pH, temperature and concentration of nutrients. Nevertheless, the reports published to date differ in the opinion of whether a particular set of ambient conditions causes induction or repression of this gene. Mukherjee et al. detected PLB1-specific mRNA in the cells cultivated at 30 °C, both in a rich medium (Sabouraud dextrose broth) containing at least 2 % glucose, and in the yeast nitrogen base supplemented with 0.5 % glucose. At 37 °C, the PLB1 expression was always lower, and required presence of serum and a mixture of phospholipids (107) . Conversely, Samaranayake et al. reported that PLB1 was expressed at 37°C, in a rich medium (YPD) without addition of serum or phospholipids (108) . Hoover and colleagues detected the highest level of PLB1 in blastospores and pseudohyphae, while hyphal form expressed reduced levels of PLB1 mRNA (109) . In contrast, Theiss et al. observed high expression of PLB1 in pseudohyphae and hyphae that were formed during the growth of C. albicans in the Lee's medium at 37 °C. The yeast form expressed one order of magnitude less PLB1 mRNA (96) . The concept of the PLB1 expression in the hyphae is supported by observations that in many cells the phospholipase activity is concentrated to the initial bud sites and hyphal tips (110,111). Plb1 was shown to be localized mostly to the hyphal tips also by immunofluorescence microscopy (112).
The Samaranayake group analyzed the expression of PLB1 in a set of C. albicans isolates from HIV infected individuals. Although the PLB1 gene was present in all of these strains, a considerable subset of isolates behaved as phospholipase-negative, exhibiting neither phospholipase secretion, nor PLB1 transcription (113). These observations indicate that an extensive variability in the PLB1 regulation may exist among the C. albicans strains. The differences in the reported data may thus be due to the properties of the strains under investigation.
Genome-wide and mutation studies using the strains ATCC 32354, SC5314 and CAF2-1 revealed that PLB1 is controlled by the transcriptional repressor TUP1. PLB1 was upregulated in the tup1 mutants (67, 109, 114) . Moreover, in the tup1 mutant the PLB1 expression became constitutive and did not vary in response to environmental stimuli (109) . PLB1 expression appears to be affected also by the signaling of the stress-activated protein kinase Hog1. Higher levels of PLB1 mRNA were detected in the parental strain than in the hog1 mutant (115).
Secreted phospholipase is likely to be regulated also on posttranslational level. However, potential regulatory role of the protein modifications has not been addressed as yet.
Role of the secreted phospholipase in virulence of C. albicans
As phospholipases are able to destroy the components of the host cell membranes, they have been regarded as virulence determinants. Of the PLB genes studied thus far, PLB1 and the respective protein appear to be the most important contribution to the virulence. Leidich et al. reported that disruption of PLB1 did not affect growth and morphology of the C. albicans cells, or their adherence to epithelial and endothelial cells. However, virulence of plb1 mutants in murine model of hematogenously disseminated candidiasis was significantly reduced. This was probably due to increased clearance rates of the PLB1-deficient strains, combined with their decreased ability to penetrate host cells (116) . The reduced invasivness of the plb1 strain was confirmed by histological analysis of stomach sections of infected mice. Without functional PLB1, C. albicans was unable to penetrate gastric mucosa. In comparison with parental strain the plb1 mutant was also less efficient in colonizing the host liver (112) . Surprisingly, PLB1 was not expressed during the growth of C. albicans on the reconstituted human oral epithelium (108) . On the other hand, elevated levels of the PLB1 mRNA were detected in the samples collected from individuals diagnosed with oral or vaginal candidiasis. Expression of PLB1 in oral or vaginal C. albicans carriers was lower and less frequent (80).
LIPASES
Lipases and esterases catalyze the hydrolysis of ester bonds of triacylglycerols. Lipases are capable of identifying and hydrolysis of insoluble or aggregated substrates and act on oil/water interface. Esterases preferentially hydrolyze more water-soluble substrates containing shorter fatty acid chains. Lipases and esterases have been identified in a wide range of organisms, and many of them have been characterized on enzymological and structural level (117) . Exploration of lipases is stimulated by the fact that they have become one of the most popular tools in biocatalysis (118, 119) .
Lipases are studied also because of their contribution to virulence of pathogenic bacteria and fungi, such as Helicobacter pylori, Pseudomonas aeruginosa, and pathogenic Candida spp. (25, (120) (121) (122) . However, secreted lipases of C. albicans have attracted less attention than proteinases and phospholipases.
The LIP1 gene was first cloned by Fu et al. (123) . This gene was transcribed only in a minimal medium supplemented with Tween or triacylglycerols as the sole carbon source. Both Tween and triacylglycerols were hydrolyzed by the LIP1 gene product, a protein consisting of 351 amino acids and containing Gly-X-Ser-X-Gly motif characteristic of lipases. C. albicans genome sequencing project revealed that the LIP1 gene product consists of 468 amino acids.
The genes LIP2 -LIP10 of C. albicans were characterized by Hube et al. (124) . These genes are strongly similar to LIP1, but no homologous genes were found in S. cerevisiae. They encode 48 -52 kDa proteins containing the Gly-X-Ser-X-Gly motif and potential Nglycosylation sites (Table 1) . With the exception of LIP7, all the LIP genes contain putative signal peptide. LIP3, LIP4, LIP5, LIP6 and LIP8 were induced in presence of Tween 40 as the sole source of carbon. When proline was used as a source of carbon, all the LIP genes with the exception of LIP7 were upregulated. Although the LIP genes were found to be expressed during the yeast-hypha transition, they appear not to depend on the morphology of the fungus. Transcripts of LIP5, LIP6, LIP8 and LIP9 were detected in organs of mice infected in a model of C. albicans peritonitis. Expression of the C. albicans LIP genes in human clinical specimens was observed by Stehr et al. (125) , who also confirmed that the transcription of these genes depends on the stage of infection. The differential expression of the LIP genes was further studied by Schofield et al. (126) , who analyzed presence of the LIP-specific mRNA during colonization and infection of alimentary tract of mice. Transcripts of LIP4-8 were detected in all the samples tested. LIP1, LIP3 and LIP9 were expressed in gastric and not in oral tissues. Importantly, LIP2 was expressed rather in colonized tissues than in infected ones. Conversely, LIP1 and LIP3 were expressed in infected gastric tissues but to a much lesser extent during colonization. Gacser et al. (127) constructed C. albicans mutants carrying different copy numbers of the LIP8 genes. The lip8 strain had a diminished lipolytic activity and was significantly less virulent in the mice model of hematogenously disseminated candidiasis.
It appears that not all the C. albicans LIP gene products display lipolytic activity. When expressed in S. cerevisiae, only LIP4, LIP6, LIP8, and LIP10 genes produce active enzymes (128) . Of all the C. albicans lipases, only Lip4 has been studied on an enzymological level. It preferred saturated, C14-C16 acyl chains and did not hydrolyze esters of short-chain fatty acids. The data on enzymological activities and specificities of other LIP gene products have not been published to date. It is therefore unclear, whether these enzymes display lipase or rather esterase activities. Extracellular esterase (monoester hydrolase) activity of C. albicans was described by Tsuboi et al. (129) . However, it is not known, if this esterase is encoded by a member of the LIP gene family, or by some other gene. The potential posttranslational modifications of the C. albicans lipases have not been elucidated either.
Sequences similar to LIP1-10 were found also in C. parapsilosis, C. tropicalis and C. krusei, but not in C. glabrata. C. parapsilosis possesses two LIP genes, but only one of them appears to encode a functional lipase. This enzyme preferentially hydrolyzes substrates containing C12 acyl chains. Biofilm formation as well as virulence was reduced in lipase-negative C. parapsilosis mutants (122).
MISCELLANEOUS
For a number of proteins listed in CGD or NCBI, the evidence of secretion is based on a single observation published in no more than one article. This diverse set of proteins includes e.g. hyaluronidase and chondroitin sulphatase (130) , alcohol dehydrogenase encoded by ADH1 (131), alpha-glucosidase encoded by MAL2 (132) , chitinase encoded by CHT3 (133) , or a member of IFF family comprising cell-wall proteins, Iff11 that unlike other IFF members lacks a potential GPI-anchor or transmembrane domain (134) . Future experiments may either confirm or disprove extracellular localization of these proteins. In contrast, multiple evidence of secretion is available for beta-Nactylhexosaminidase.
Beta-N-Acetylhexosaminidase
The HEX1 gene encodes beta-Nacetylhexosaminidase, an enzyme that is secreted to periplasm and to the extracellular space. This hydrolytic enzyme was previously denominated chitobiase, because it acts on the chitin oligomers N,N'-diacetylchitobiose and N,N'N''-triacetylchitobiose, releasing Nacetylglucosamine. But since this enzyme can cleave a broad range of substrates (135), the name was changed to beta-N-acetylhexosaminidase, also known as HexNAcase. HexNAcases are produced by a variety of fungi, but also by bacteria and mammals. Among pathogenic Candida species, high levels of extracellular HexNAcase activity were detected in C. albicans and C. dubliniensis. The HexNAcase plate assay can thus be used for an easy distinction of these two species from C. glabrata, C. guillermondii, C. krusei or C. tropicalis, that do not produce this enzyme (136) .
The HexNAcase from C. albicans is a highly glycosylated, relatively stable enzyme with a maximum activity at pH 4 (135) . Its production is induced by presence of N-acetylglucosamine, which can serve as the only source of carbon and nitrogen (137) . HexNAcase is considered to be a part of a nutrient-scavenging system, that may give the cells a growth advantage. It has been suggested that extracellular HexNAcase may contribute to the C. albicans pathogenicity by cleaving host glycoproteins and releasing N-acetylglucosamine that may serve as a nutrient source. It is also likely that HexNAcase plays a role in the chitin turnover (137) . HexNAcase-defficient mutant was less pathogenic in a mouse model than the parental strain (138).
SUMMARY AND PERSPECTIVE
Some of the secreted proteins mentioned in this review are considered as highly relevant for the C. albicans virulence. However, the contribution of a particular gene/protein to the fungus invasion and pathogenesis is difficult to dissect, especially because of a high degree of functional redundancy within the families. The continuing efforts of many laboratories may therefore result in reinterpretation of the relative importance of the individual proteins.
Although secreted aspartic proteinases of C. albicans have been characterized thoroughly, some pieces of information are still missing. The structures of Sap2 and Sap3 have been published, but comparative data addressing Sap2 and Sap3 specificity are scarce (40). Other members of the SAP family have not been studied so extensively. Sap7 is rather enigmatic, and the precise roles of Sap9 and Sap10 remain unknown. The information on the secreted phospholipases are less detailed in comparison with the SAP family. No structural studies have been published and the amount of data concerning potential inhibitors of these enzymes is rather limited. Possible role of the Candida phospholipases in signaling between the pathogen and the host has to be elucidated. Lipases secreted by C. albicans have been marginalized, and clearly deserve more attention. Biological and biochemical data concerning the LIP family are sparse.
This review obviously covers only a part of the C. albicans secretome. Future experiments are likely to provide information on more secreted proteins. Some of them might be encoded by ORFs whose function is currently unknown.
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